Cercar
01/10/2022
Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study
Espindola, R, Vella, V, Benito, N, Mur, I, Tedeschi, S, Rossi, N, Hendriks, JGE, Sorli, L, Murillo, O, Scarborough, M, Scarborough, C, Kluytmans, J, Ferrari, MC, Pletz, MW, Mcnamara, I, Escudero-Sanchez, R, Arvieux, C, Batailler, C, Dauchy, FA, Liu, WY, Lora-Tamayo, J, Praena, J, Ustianowski, A, Cinconze, E, Pellegrini, M, Bagnoli, F, Rodriguez-Bano, J, Del Toro, MD. Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study. CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(10)DOI:10.1016/j.cmi.2022.05.010. PMID:35597508. IF:14.200(Q1/1D).
01/09/2022
COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement Therapy
Vart, P, Jager, KJ, Arnol, M, Duivenvoorden, R, Franssen, CFM, Groeneveld, M, Hemmelder, MH, Lepeytre, F, Malfait, T, Midtvedt, K, Mitra, S, Facundo, C, Noordzij, M, Reina, CC, Safak, S, Toapanta, N, Hilbrands, LB, Gansevoort, RT. COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement Therapy. Kidney International Reports. 2022; 7(9)DOI:10.1016/j.ekir.2022.06.007. PMID:35757188. IF:6.000(Q1/2D).
01/08/2022
Decreased mortality among patients with catheter- related bloodstream infections at Catalan hospitals (2010-2019)
Badia-Cebada, L, Penafiel, J, Lopez-Contreras, J, Pomar, V, Martinez, JA, Santana, G, Cuquet, J, Montero, MM, Hidalgo-Lopez, C, Andres, M, Gimenez, M, Quesada, MD, Vaque, M, Iftimie, S, Gudiol, C, Perez, R, Coloma, A, Marron, A, Barrufet, P, Marimon, M, Lerida, A, Claros, M, Ramirez-Hidalgo, MF, Pardo, GG, Martinez, MJ, Chamarro, EL, Jimenez-Martinez, E, Hornero, A, Limon, E, Lopez, M, Calbo, E, Pujol, M, Gasch, O. Decreased mortality among patients with catheter- related bloodstream infections at Catalan hospitals (2010-2019). JOURNAL OF HOSPITAL INFECTION. 2022; 126DOI:10.1016/j.jhin.2022.05.009. PMID:35594988. IF:6.900(Q1/2D).
01/07/2022
Clinical usefulness of quantifying microbial load from diabetic foot ulcers: A multicenter cohort study
Soldevila-Boixader, L, Mur, I, Morata, L, Sierra, Y, Rivera, A, Bosch, J, Montero-Saez, A, Fernandez-Reinales, AJ, Marti, S, Benito, N, Murillo, O. Clinical usefulness of quantifying microbial load from diabetic foot ulcers: A multicenter cohort study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2022; 189DOI:10.1016/j.diabres.2022.109975. PMID:35777672. IF:5.100(Q2/3D).
30/06/2022
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
Canada-Garcia, JE, Moure, Z, Sola-Campoy, PJ, Delgado-Valverde, M, Cano, ME, Gijon, D, Gonzalez, M, Gracia-Ahufinger, I, Larrosa, N, Mulet, X, Pitart, C, Rivera, A, Bou, G, Calvo, J, Canton, R, Gonzalez-Lopez, JJ, Martinez-Martinez, L, Navarro, F, Oliver, A, Palacios-Baena, ZR, Pascual, A, Ruiz-Carrascoso, G, Vila, J, Aracil, B, Perez-Vazquez, M, Oteo-Iglesias, J. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3. Frontiers in Microbiology. 2022; 13DOI:10.3389/fmicb.2022.918362. PMID:35847090. IF:5.200(Q2/3D).
16/05/2022
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Quindós G., Miranda-Cadena K., San-Millán R., Borroto-Esoda K., Cantón E., Linares-Sicilia M.J., Hamprecht A., Montesinos I., Tortorano A.M., Prigitano A., Vidal-García M., Marcos-Arias C., Guridi A., Sanchez-Reus F., Machuca-Bárcena J., Rodríguez-Iglesias M.A., Martín-Mazuelos E., Castro-Méndez C., López-Soria L., Ruiz-Gaitán A., Fernandez-Rivero M., Lorenzo D., Capilla J., Rezusta A., Pemán J., Guarro J., Pereira J., Pais C., Romeo O., Ezpeleta G., Jauregizar N., Angulo D., Eraso E.. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study. Frontiers in Cellular and Infection Microbiology. 2022; 12DOI:10.3389/fcimb.2022.906563. PMID:35651755. IF:5.700(Q1/3D).